CBA
ENTX icon

Coastal Bridge Advisors’s Entera Bio ENTX Stock Holding History

Coastal Bridge Advisors’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-60,060
Closed -$249K – 134
2019
Q1 		$249K Buy
+60,060
New +$243K 0.09% 102

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Coastal Bridge Advisors's ENTX Position: Q2 2019 in Review

Coastal Bridge Advisors sold out of Entera Bio (ENTX) in Q2 2019, closing a stake of 60,060 shares — an estimated $249K sold.

Coastal Bridge Advisors first reported a position in ENTX in Q1 2019 and held it in 1 quarter. The position peaked at $249K in Q1 2019. 6 funds tracked by Wall St. Rank hold ENTX as of Q2 2019.

  • Coastal Bridge Advisors reported no remaining Entera Bio position as of Q2 2019 after selling out during the quarter.
  • Coastal Bridge Advisors sold 60,060 Entera Bio shares in Q2 2019, an estimated $249K.
  • Coastal Bridge Advisors first reported a position in Entera Bio in Q1 2019 and held it in 1 quarter.
  • Coastal Bridge Advisors's Entera Bio position peaked at $249K in Q1 2019.
  • 6 funds tracked by Wall St. Rank held Entera Bio as of Q2 2019.

Based on Coastal Bridge Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.